The complete gene cluster of the antitumor agent gilvocarcin V and its implication for the biosynthesis of the gilvocarcins

Journal of the American Chemical Society

Volumn 125, Issue 26, 2003, Pages 7818-7819

  Fischer, Carsten ^a   Lipata, Fredilyn ^a   Rohr, Jürgen ^a  

^a University of Kentucky   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; GILVOCARCIN V;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BIOSYNTHESIS; CLINICAL PATHWAY; DRUG CONFORMATION; DRUG STRUCTURE; GENE CLUSTER; GLYCOSYLATION; NONHUMAN; STREPTOMYCES; STRUCTURE ANALYSIS;

AMINOGLYCOSIDES; ANTI-BACTERIAL AGENTS; ANTIBIOTICS, ANTINEOPLASTIC; MULTIGENE FAMILY; STREPTOMYCES;

EID: 0038541734     PISSN: 00027863     EISSN: None     Source Type: Journal    
DOI: 10.1021/ja034781q     Document Type: Article

References (29)

1. (a) Hirayama, N.; Takahashi, K.; Shirahata, K.; Ohashi, Y.; Sasada, Y. Bull. Chem. Soc. Jpn. 1981, 54, 1338-1342.
2. (b) Krohn, K.; Rohr, J. Topics Curr. Chem. 1997, 188, 127-195, and references cited therein.
3. Hosoya, T.; Takashiro, E.; Matsumoto, T.; Suzuki, K. J. Am. Chem. Soc. 1994, 116, 1004-1015.
4. (a) Knobler, R. M.; Radlwimmer, F. B.; Lane, M. J. Nucleic Acid Res. 1992, 20, 4553-4557.
5. (b) Matsumoto, A.; Hanawalt, P. C. Cancer Res. 2000, 60, 3921-3926.
6. (a) Yamashita, N.; Shin-Ya, K.; Furihata, K.; Hayakawa, Y.; Seto, H. J. Antibiot. 1998, 51, 1105-1108.
7. (b) Nakashima, T.; Fujii, T.; Sakai, K.; Tomohiro, S.; Kumagai, H.; Yoshioka, T. U.S. Patent 6,030,951, 2000.
8. Morimoto, M.; Okubo, S.; Tomita, F.; Marumo, H. J. Antibiot. 1981, 34, 701-707.
9. Breiding-Mack, S.; Zeeck, A. J. Antibiot. 1987, 40, 953-960.
10. (a) Yamashita, Y.; Nakano, H. Nucleic Acids Res. Symp. Ser. 1988, 20, 65-67.
11. (b) Elespuru, R. K.; Gonda, S. K. Science 1984, 223, 69-71.
12. Oyola, R.; Arce, R.; Alegria, A. E.; Garcia, C. Photochem. Photobiol. 1997, 65, 802-810, and references cited therein.
13. Takahashi, K.; Tomita, F. J. Antibiot. 1983, 36, 1531-1535.
14. Rix, U.; Fischer, C.; Remsing, L. L.; Rohr, J. Nat. Prod. Rep. 2002, 19, 542-580, and references cited therein.
15. (a) Decker, H.; Gaisser, S.; Pelzer, S.; Schneider, P.; Westrich, L.; Wohlleben, W.; Bechthold, A. FEMS Microbiol. Lett. 1996, 141, 195-201.
16. (b) Hopwood, D. A. Chem. Rev. 1997, 97, 2465-2497.
17. Altschul, S. F.; Madden, T. L.; Schaffer, A. A.; Zhang, J. H.; Zhang, Z.; Miller, W.; Lipman, D. J. Nucleic Acid Res. 1997, 25, 3389-3402.
18. Staunton, J.; Weissmann, K. J. Nat. Prod. Rep. 2001, 18, 380-416.
19. Summers, R. G.; Ali, A.; Shen, B.; Wessel, W. A.; Hutchinson, C. R. Biochemistry 1995, 34, 9389-9402.
20. Novakova, R.; Bistakova, J.; Homerova, D.; Rezuchova, B.; Kormanec, J. Gene 2002, 297, 197-208.
21. (a) Hutchinson, C. R. Chem. Rev. 1997, 97, 2525-2536.
22. (b) Moore, B. S.; Hertweck, C. Nat. Prod. Rep. 2002, 19, 70-99.
23. (c) Marti, T.; Hu, Z.; Pohl, N. L.; Shah, A. N.; Khosla, C. J. Biol. Chem. 2000, 275, 33443-33448.
24. (a) Yang, K.; Han, L.; Ayer, S. W.; Vining, L. C. Microbiology 1996, 142, 123-132.
25. Vining, L. C., personal communication.
26. From the original X-ray resolved structure, the wrong enantiomer of GV (with an L-fucofuranose moiety) was chosen, which dominates the literature, and even remains in the newest literature on GV, although the correct structure (with D-fucofuranose) was established in 1994 by Suzuki et al. through total synthesis.
27. Palmacci, E. R.; Seeberger, P. H. Org. Lett. 2001, 3, 1547-1550.
28. (a) Künzel, E.; Faust, B.; Oelkers, C.; Weissbach, U.; Bearden, D. W.; Weitnauer, G.; Westrich, L.; Bechthold, A.; Rohr, J. J. Am. Chem. Soc. 1999, 121, 11058-11062.
29. (b) Westrich, L.; Domann, S.; Faust, B.; Bedford, D.; Hopwood, D. A.; Bechthold, A. FEMS Microbiol. Lett. 1999, 170, 381-387.